Evidence map›Paper›PMID 29574062›Full record

ReviewMatrix biology : journal of the International Society for Matrix Biology2019

Hyaluronan in inflammatory bowel disease: Cross-linking inflammation and coagulation.

Aaron C Petrey, Carol A de la Motte

Open access · greenAbstract readReview
In one paragraph

Review in Matrix biology : journal of the International Society for Matrix Biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. TSG6 hyaluronan matrix remodeling dampens the inflammatory response during colitis.Matrix biology : journal of the International Society for Matrix Biology · 2023
    Article
  13. Article
  14. Article
  15. Defining the versican interactome in lung health and disease.American journal of physiology. Cell physiology · 2022
    Review
  16. Microbiota medicine: towards clinical revolution.Journal of translational medicine · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Development of Inflammatory Bowel Diseases Registry Software.Middle East journal of digestive diseases · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Aaron C PetreyDepartment of Pathobiology, Cleveland Clinic Lerner Research Institute, Cleveland, OH, United States.
Carol A de la MotteDepartment of Pathobiology, Cleveland Clinic Lerner Research Institute, Cleveland, OH, United States. Electronic address: delamoc@ccf.org.
Cleveland Clinic Lerner College of Medicine · US

Funding

VERSICAN PROTEOLYSIS AND REGULATION OF VASCULAR SMOOTH MUSCLEP01HL107147 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI LAUER, MARK E · 2011 to 2017
$16.1M
Tissue Cytokine Sequestration and Immune Regulation in AutoimmunityU01AI101984 · NIAID · STANFORD UNIVERSITY · PI BOLLYKY, PAUL L · 2012 to 2021
$5.0M
Lymph Node Extracellular Matrix in Antigen Presentation and Immune RegulationR01DK096087 · NIDDK · STANFORD UNIVERSITY · PI BOLLYKY, PAUL L · 2012 to 2021
$3.4M
ECM Costimulation of Immunoregulatory Pathways in Airway InflammationR01HL113294 · NHLBI · STANFORD UNIVERSITY · PI BOLLYKY, PAUL L · 2012 to 2016
$2.0M
Platelet-hyaluronan interactions as regulators of inflammation and thrombosisR00HL135265 · NHLBI · UNIVERSITY OF UTAH · PI PETREY, AARON CHRISTOPHER · 2020 to 2022
$747k
Platelet-hyaluronan interactions as regulators of inflammation and thrombosis."K99HL135265 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI PETREY, AARON CHRISTOPHER · 2017 to 2018
$280k
NHLBI NIH HHS K99 HL135265NHLBI NIH HHS P01 HL107147NHLBI NIH HHS R00 HL135265NHLBI NIH HHS R01 HL113294NIAID NIH HHS U01 AI101984NIDDK NIH HHS R01 DK096087
6 · The paper itself

Abstract

Hyaluronan, a major extracellular matrix component, is an active participant in many disease states, including inflammatory bowel disease (IBD). The synthesis of this dynamic polymer is increased at sites of inflammation. Hyaluronan together with the enzymes responsible for its synthesis, degradation, and its binding proteins, directly modulates the promotion and resolution of disease by controlling recruitment of immune cells, by release of inflammatory cytokines, and by balancing hemostasis. This review discusses the functional significance of hyaluronan in the cells and tissues involved in inflammatory bowel disease pathobiology.

Indexed as

CytokinesExtracellular MatrixHumansHyaluronan SynthasesHyaluronic AcidInflammatory Bowel DiseasesCytokinesHyaluronan SynthasesHyaluronic AcidCoagulationHyaluronanInflammationInflammatory bowel diseaseMegakaryocytePlatelet

Identifiers

PMID29574062
PMCPMC6150849
OpenAlexW2791388548

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.